Blog post -

Timesulin opens its (web) doors to the public

It is an immensely proud day in my life as a person living with diabetes for over 26 years to announce the European launch of Timesulin. Timesulin was an idea originally conceived in 2008 by co-founder – and my brother – Andreas Sjölund to once and for all end the issue I faced with forgetting if I have taken my insulin injections or not.

As somebody who takes at least four insulin injections per day – 28 shots per week, 120 shots per month or a minimum of 1460 injections per year – I’m going to forget sometimes, right? For many years I asked my doctors and nurses why there was not a simple solution to this problem and I could never get an answer. To this day there still remains no way for those of us who use different types and brands of insulin to know with certainty when we last took our insulin. Well, I should say up to yesterday there was no solution. The solution has arrived and now we can focus all that energy into other aspects of our lives! Living with diabetes is a 24/7 job. Despite our best efforts, it’s tough everyday – we at Timesulin are aiming to make one aspect of life just a little bit more simple.

Some interesting facts of how we got to this point:

There have been over 100 iterations of the design of the product with many, many different features before we got to the final product. Below is an early 3D rendering that the third co-founder and Timesulin CTO Marcel Botha created – my directive as a user? Make it less bulky!

We also tested many different formations of the clip to see how we could maximise function and aesthetics of the product. After all, we didn’t want our product to create any additional bulk. It needs to fit in our pockets, our jeans, our backpacks or handbags and our lives – just as well as the original.

We also tested lots of different features in the product including alarms, memory functions, dosing information etc. While I am sure that all of us living with diabetes can benefit from more information and more data – sometimes we just want to make our lives a little bit simpler and balanced. Our idea was to produce something that was so easy to use that it didn’t even require an instruction manual. No new systems to learn, no menus to navigate, no clocks to program and no buttons to push. It does one important thing well – when you get that feeling in your body wondering if you took your insulin or not – Timesulin lets you know when the last time you took your insulin was. Simple.

Today we are releasing the first three Timesulin caps that together cover 10 different types of the most common insulin types for people with both type 1 and type 2 diabetes. We have received many thousands of requests to develop caps for additional pens and all I can say is – watch this space, we are hoping to be able to solve this problem for everybody.

Being a Timesulin user over the last months has been a fantastic experience for me. It hasn’t solve all issues with my diabetes, but it makes one aspect of it easier for me. I hope that the product works for you and gives you a little more time to concentrate on something other than your diabetes.

Now help us tell the world about this handy new device so we can help as many others living with this same frustration every day lead a life that is just a little bit easier! And if you’ve already received your Timesulin cap, please share the experience with us via our Facebook page, or via Twitter. I can’t wait to hear from you!

Thank you for all the support thus far,

/John, a proud person with diabetes of over 26 years.

Topics

  • Diseases

Categories

  • insulin smart cap
  • john sjolund
  • marcel botha
  • smart cap
  • timesulin
  • insulin replacement cap
  • insulin reminder
  • insulin pen
  • diabetics
  • diabetic
  • diabetes
  • andreas sjolund

Contacts

John Sjölund

Press contact CEO & Co-founder Sales and distribution, company spokesperson +44 (0)20 3287 2760 Timesulin Spokespeople

Marie Rönn

Press contact Marketing Manager Account Management and Marketing +46 (0) 733 311 722

Related content